(Q53883940)

22 May 2018

title

Frequent promoter hypermethylation and low expression of the MGMT gene in oligodendroglial tumors. (English)

1 reference

22 May 2018

1 reference

1 reference

5

Guido Reifenberger

1 reference

22 May 2018

2

Marietta Wolter

1 reference

22 May 2018

3

Jörg Felsberg

1 reference

22 May 2018

Maria Möllemann

1

1 reference

22 May 2018

V Peter Collins

series ordinal

4

1 reference

22 May 2018

language of work or name

English

0 references

publication date

1 January 2005

1 reference

22 May 2018

International Journal of Cancer

published in

1 reference

22 May 2018

volume

113

1 reference

22 May 2018

issue

3

1 reference

22 May 2018

page(s)

379-385

1 reference

22 May 2018

Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.

cites work

1 reference

MGMT: its role in cancer aetiology and cancer therapeutics

21 January 2018

1 reference

Generating mutations but providing chemosensitivity: the role of O6-methylguanine DNA methyltransferase in human cancer

21 January 2018

1 reference

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents

21 January 2018

1 reference

Aberrant promoter methylation of multiple genes in oligodendrogliomas and ependymomas.

21 January 2018

1 reference

Correlation between promoter hypermethylation of the O6-methylguanine-deoxyribonucleic acid methyltransferase gene and prognosis in patients with high-grade astrocytic tumors treated with surgery, radiotherapy, and 1-(4-amino-2-methyl-5-pyrimidinyl)

21 January 2018

1 reference

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

21 January 2018

1 reference

Cellular mechanisms targeted during astrocytoma progression

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.20575

1 reference

22 May 2018

PubMed ID

15455350

1 reference

22 May 2018